Marketed as Bulk Active Ingredient

A category specifying that a drug is marketed as the brand-generic version of the product by the holder of an approved New…

A marketing category specifying that an approved drug product is manufactured and packaged exclusively for a Private Label Distributor, and not otherwise…

A removal or correction by manufacturer or owner of a marketed product that the FDA considers to be either no violation or…

Specific molecular molecules or signatures that indicate that a cell will become neoplastic at a future time.

The goal of the network is to evaluate biochemical, immunologic, genetic, and other quantifiable markers for diagnosis and prognosis of urinary bladder…

Strategies and technologies for molecular phenotyping and biological marker discovery to improve understanding of disease and aid the pharmaceutical industry's ability to…